Hematopoietic progenitor cell mobilization with “just-in-time” plerixafor approach is a cost-effective alternative to routine plerixafor useLauren Veltri, Abraham S. Kanate, Luo Jin et al.|Cytotherapy|2015Cited by 33
Chemomobilization with (R)-ICE (rituximab, ifosfamide, carboplatin, etoposide) compared to G-CSF and plerixafor (G+P) mobilization in lymphoid malignancies.Lauren Veltri, Abraham S. Kanate, Binod Dhakal et al.|Journal of Clinical Oncology|2015Cited by 0